Hello
Aconplia contains Rimonabant, the long awaaitred breakthrough drug by Sanofi for the treatment of obrsity and smoking cessation.
Acopmlia represents one of the latest and indeed a most novel method for controlling body weight. Acomplia operates by beign a cannabinoid receptor antagonist. This means that Acomplia prevents the normal action of endogenous cannabinoid in the brain from stimulating the so-called CB1 receptors. It would appear that these receptors stimulate appetite and therefore when they are “subdued†so is the need to eat.
The clinical trials that have been run over the past few years are impressive and have shown that these receptor sites may be responsible for more than just appetite, because the results show that Acomplia also aids people to stop smoking and even improves cardiovascular factors such as cholesterol ratios.
Bye
